Two MSRA cells surrounded by solid lipid nanoparticles designed to target MSRA specifically. The particles are used to deliver a deadly biocide as part of a new therapy developed by Waterloo Professor Emmanuel Ho and colleagues at the University of Manitoba that can kill antibiotic resistant pathogens. Scientists have developed a new therapy to combat deadly bacteria that is infecting hospital patients worldwide.
Scientists have developed a new therapy to combat deadly bacteria that is infecting hospital patients worldwide.
McMaster’s Michael G. DeGroote School of Medicine is a neighbour of the Waterloo School of Pharmacy: both are located at the Health Sciences Campus in downtown Kitchener. Over the years, the schools have taken advantage of their proximity to collaborate on projects and events.
In December, McMaster Medicine recognized Waterloo Pharmacy’s Elaine Lillie as an invaluable partner and honoured her with the Excellence in Collaboration Award for Interprofessional Education.
As opioid overdoses continue to rise in Ontario, so too does the number of Ontarians seeking services to manage opioid withdrawal. Methadone maintenance treatment (MMT) is one such service: this treatment involves long-term prescribing of methadone, an opioid that replaces the drug the patient was originally dependent on. This safely controlled dose of methadone is then tapered. The goal is that the patient will eventually no longer require the treatment.